levothyroxine sodium 0.02 MG/ML Oral Solution [Thyquidity]
levothyroxine sodium
RxCUI: 2473282
What the CMS Formulary Data Shows for levothyroxine sodium 0.02 MG/ML Oral Solution [Thyquidity]
Per the CMS 2026 Part D formulary file, levothyroxine sodium 0.02 MG/ML Oral Solution [Thyquidity] (RxNorm concept RXCUI 2473282, generic name levothyroxine sodium) appears on 1 distinct formulary file spanning 1 Medicare Part D plan offering - 0% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 2 to Tier 2, with a cross-plan average of Tier 2.
Real-world access to levothyroxine sodium 0.02 MG/ML Oral Solution [Thyquidity] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 8,687,969 Part D beneficiaries filled levothyroxine sodium 0.02 MG/ML Oral Solution [Thyquidity] in 2023, with total plan-and-beneficiary spending of $653,594,902 and an average per-beneficiary annual cost of $75.23. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry levothyroxine sodium 0.02 MG/ML Oral Solution [Thyquidity] today.
Coverage Details
- Formularies covering
- 1
- Plans covering
- 1
- Coverage rate
- 0%
- Tier range
- Tier 2, Generic
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 8,687,969
- Total spending
- $653,594,902
- Avg per beneficiary
- $75.23
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering levothyroxine sodium 0.02 MG/ML Oral Solution [Thyquidity]
1 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| CalOptima Health OneCare Complete (HMO D-SNP) | ORANGE COUNTY HEALTH AUTHORITY | T2 | No | $0 | CA |
Frequently Asked Questions
Is levothyroxine sodium 0.02 MG/ML Oral Solution [Thyquidity] covered by Medicare Part D?
Yes, levothyroxine sodium 0.02 MG/ML Oral Solution [Thyquidity] is covered by 1 Medicare Part D plans (0% of all Part D formularies).
What tier is levothyroxine sodium 0.02 MG/ML Oral Solution [Thyquidity] on Medicare Part D plans?
levothyroxine sodium 0.02 MG/ML Oral Solution [Thyquidity] averages Tier 2 across Part D plans, ranging from Tier 2 to Tier 2.
Does levothyroxine sodium 0.02 MG/ML Oral Solution [Thyquidity] require prior authorization?
0% of Part D formularies require prior authorization for levothyroxine sodium 0.02 MG/ML Oral Solution [Thyquidity]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on levothyroxine sodium 0.02 MG/ML Oral Solution [Thyquidity]?
In 2023, total Medicare Part D spending on levothyroxine sodium 0.02 MG/ML Oral Solution [Thyquidity] was $653,594,902, covering 8,687,969 beneficiaries. The average spend per beneficiary was $75.23.
Read our methodology - how this data is sourced, computed, and verified.